High Content Screening Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global High Content Screening Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global High Content Screening Market Research
Report The latest report by IMARC, titled High
Content Screening Market Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2023-2028 " the global high content screening
market size reached US 1.2 Billion in 2022.
High content screening (HCS) refers to an
advanced approach of cell-based screening in drug
discovery and systems biology that utilizes
visualization tools to gather quantitative data
from cell populations. It involves the usage of
quantitative data analysis and automated imaging
in a high-throughput format. Also known as high
content analysis, it employs multicolor
fluorescence imaging to analyze several
biochemical and physical characteristics of the
sample cells. As a result, this analytical method
of automated microscopy assists in complex
multivariate drug profiling and toxicity
studies. Request Free Sample Report
https//www.imarcgroup.com/high-content-screening-
market/requestsample
4
Report Description and Highlights
Report Description

Global High Content Screening Market Trends The
global market is majorly driven by the increasing
incidences of chronic neurodegenerative diseases,
such as Parkinsons and Alzheimers. This has led
to the growing need for affordable and effective
drug discovery systems on the global level, which
is providing an impetus to the market growth. HCS
is widely preferred by professionals as this
method of microscopy aids in analyzing the
potential toxicity of chemicals and complex
substances in a resource-efficient manner. The
market is further driven by continual
developments in informatics solutions and imaging
instruments. Moreover, numerous key players are
also introducing innovative HCS equipment in the
market that are equipped with software platforms
and artificial intelligence (AI) systems in an
attempt to improve the visualization capabilities
of the systems. Some of the other factors
contributing to the market growth include the
growing geriatric population, the advent of
automated systems for analyzing cell separation
and scalability, and extensive research and
development (RD) activities conducted by major
players. On account of the aforementioned
factors, the market is anticipated to grow at a
CAGR of 8.4 during 2023-2028. Looking forward,
the market value is projected to reach a strong
growth during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Product In
struments Cell Imaging and Analy
sis Systems Flow Cytometers
Consumables Reagents Ass
ay Kits Microplates
Other Consumables Software
Services Accessories Breakup by Appl
ication Target Identification and Valid
ation Primary Screening and Secondary Sc
reening Toxicity Studies Compo
und Profiling Other Applications

6
Report Description and Highlights
Report Description
Breakup by End-User Pharmaceutical and
Biotechnology Companies Academic and Gov
ernment Institutes Contract Research Org
anizations (CROs) Breakup by Region No
rth America United States
Canada Asia Pacific
China Japan
India South Korea
Australia Indonesia
Others Europe
Germany France

7
Report Description and Highlights
Report Description
United Kingdom
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Becton Dickinson and Company Bio-Rad Laboratories
  Inc. Biotek Instruments Inc. Danaher Corporation G
  E Healthcare Merck Millipore Perkinelmer Inc. Teca
  n Group Ltd. Thermo Fisher Scientific Yokogawa Ele
  ctric Corporation
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/high-content-screening-
  market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us